FDA Inspection
Xellia Pharmaceuticals Ltd.Xellia Pharmaceuticals Ltd. – FDA Inspection, Dec 8, 2021
Record Details
This FDA Inspection record concerns Xellia Pharmaceuticals Ltd., with an inspection on December 8, 2021, issued by the Center for Drug Evaluation and Research, covering drugs.
- Company
- Xellia Pharmaceuticals Ltd.
- Inspection Date
- December 8, 2021
- Product Type
- Drugs
View Company Profile
ID · 2dafe0f8-7c76-4b6e-9e1a-910ed586f074
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1171686
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Xellia Pharmaceuticals Ltd.
3| Date | Classification | Office | Project area |
|---|---|---|---|
| February 1, 2019 | Not classified | Office of Inspections and Investigations | |
| December 5, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 24, 2011 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Xellia Pharmaceuticals Ltd.
- FDA Inspection 1082483 - 2019-02-01
- FDA Inspection 905986 - 2014-12-05
- FDA Inspection 749888 - 2011-06-24
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.